Media Summary: One important piece of the puzzle in cholangiocarcinoma (CCA) research is understanding how inherited genetics may influence ... We will explore the emerging role of histotripsy—a noninvasive, focused ultrasound therapy—in the management of patients with ... Living with serious illness raises important questions about what matters most—to us and to the people who care about us.
Ccf Webinar A Multi Institutional - Detailed Analysis & Overview
One important piece of the puzzle in cholangiocarcinoma (CCA) research is understanding how inherited genetics may influence ... We will explore the emerging role of histotripsy—a noninvasive, focused ultrasound therapy—in the management of patients with ... Living with serious illness raises important questions about what matters most—to us and to the people who care about us. Cholangiocarcinoma, or bile duct cancer, can be challenging to manage. Join us to learn about a new, personalized approach ... There is an increasingly recognized hereditary component to the development of cholangiocarcinoma (CCA), but no large ... Join the Cholangiocarcinoma Foundation and Society of Interventional Oncology (SIO) for a compelling
Biomarkers are mutations on cancer cells that we can test for and sometimes treat. How do we find them, how did they get there, ... In this presentation, we will hear about what Integrative Medicine is, what it entails, and how we are advancing the field to create a ... This presentation covered the Human Epidermal Growth Factor Receptor-2 (HER2) protein and its role in cancer, with a focus on ... The standard of care regimen for the 1L treatment of biliary tract cancers (BTCs) applies to the overall patient population ... On August 12, the Cholangiocarcinoma Foundation announced a partnership with Ciitizen. This partnership is formed around the ... We reviewed the side effects of FGFR inhibitors and the supportive care treatments to help manage them. Sponsored by Taiho ...
The National Cancer Institute (NCI) offers clinical trials for patients with isolated liver disease using hepatic artery infusion pumps, ...
